Sufentanil Kalceks

Use in adults
Intravenous administration of sufentanil is indicated for use in anaesthesia during all surgical procedures in patients with endotracheal intubation receiving mechanical ventilation:

• as an analgesic component during induction and maintenance of balanced anaesthesia;
• as an anaesthetic agent for induction and maintenance of anaesthesia.

Using epidural administration sufentanil is indicated as a supplementary analgesic agent to epidural bupivacaine:

•  for postoperative treatment of pain following general, thoracic and orthopaedic surgery and caesarean section;
• for treatment of pain during labour and vaginal delivery.

Use in paediatric population
Intravenous sufentanil is indicated as an analgesic agent for use during induction and/or maintenance of balanced general anaesthesia in children over the age of 1 month.

Epidural sufentanil is indicated in children aged 1 year and over for the postoperative management of pain following general surgery, thoracic or orthopaedic procedures.

Prescription medication. Information for healthcare professionals only. For full information about the medicine, see the Summary of Product Characteristics.
Advertising developed or revised (02.2023). Advertiser: AS Kalceks.